Donald Trump imposed Section 232 tariffs on patented pharmaceuticals and ingredients, including a 100% rate, with implementation in 120–180 days depending on company size. Lower rates apply to key allies, while firms agreeing to onshoring and pricing terms can receive reduced or zero tariffs through 2029. Generics and certain specialty drugs are exempt. The White House said the move addresses national security risks tied to import reliance and has already prompted about $400 billion in pledged p

Donald Trump imposed Section 232 tariffs on patented pharmaceuticals and ingredients, including a 100% rate, with implementation in 120–180 days depending on company size. Lower rates apply to key allies, while firms agreeing to onshoring and pricing terms can receive reduced or zero tariffs through 2029. Generics and certain specialty drugs are exempt. The White House said the move addresses national security risks tied to import reliance and has already prompted about $400 billion in pledged pharmaceutical investment in the U.S.